BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
1-Year Est. Return 36.47%
This Quarter Est. Return
1 Year Est. Return
+36.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$676M
AUM Growth
-$174M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1 +$14.3M
2 +$8.41M

Top Sells

1 +$2.35M
2 +$1.44M
3 +$632K
4
NAUT icon
Nautilus Biotechnolgy
NAUT
+$591K

Sector Composition

1 Healthcare 99.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$4.25B
$219M 32.46%
10,719,110
NUVL icon
2
Nuvalent
NUVL
$7.05B
$103M 15.19%
1,447,267
PHVS icon
3
Pharvaris
PHVS
$1.45B
$51.9M 7.67%
3,303,381
IRON icon
4
Disc Medicine
IRON
$3.22B
$48.8M 7.22%
983,500
DNTH icon
5
Dianthus Therapeutics
DNTH
$1.38B
$48.8M 7.22%
2,689,707
SVRA icon
6
Savara
SVRA
$848M
$48.8M 7.21%
17,600,621
+3,035,164
SLDB icon
7
Solid Biosciences
SLDB
$418M
$29.3M 4.33%
7,911,669
+3,877,087
OLMA icon
8
Olema Pharmaceuticals
OLMA
$611M
$25.7M 3.81%
6,843,954
-626,260
RPID icon
9
Rapid Micro Biosystems
RPID
$135M
$22.3M 3.29%
8,434,560
CDTX icon
10
Cidara Therapeutics
CDTX
$2.68B
$15.1M 2.24%
703,080
UPB
11
Upstream Bio Inc
UPB
$1.4B
$14M 2.08%
2,295,322
ANNX icon
12
Annexon
ANNX
$353M
$10.1M 1.5%
5,249,069
AVIR icon
13
Atea Pharmaceuticals
AVIR
$256M
$7.43M 1.1%
2,485,638
KYTX icon
14
Kyverna Therapeutics
KYTX
$292M
$6.5M 0.96%
3,368,370
XFOR icon
15
X4 Pharmaceuticals
XFOR
$316M
$4M 0.59%
563,859
CABA icon
16
Cabaletta Bio
CABA
$284M
$3.82M 0.57%
2,760,888
TNGX icon
17
Tango Therapeutics
TNGX
$1.04B
$3.72M 0.55%
2,712,008
XLO icon
18
Xilio Therapeutics
XLO
$42M
$3.31M 0.49%
4,566,817
MRSN icon
19
Mersana Therapeutics
MRSN
$45.9M
$2.98M 0.44%
346,547
IPSC icon
20
Century Therapeutics
IPSC
$52.2M
$2.58M 0.38%
5,410,361
CCCC icon
21
C4 Therapeutics
CCCC
$236M
$1.78M 0.26%
1,111,910
IVVD icon
22
Invivyd
IVVD
$392M
$1.09M 0.16%
1,799,595
NAUT icon
23
Nautilus Biotechnolgy
NAUT
$171M
$923K 0.14%
1,072,421
-686,579
NAMSW icon
24
NewAmsterdam Pharma Warrant
NAMSW
$124M
$899K 0.13%
100,000
SYRS
25
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-2,750,151